Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Affected individuals are typically characterised by lipoatrophic diabetes, insulin resistance and hepatic steatosis ( Agonists of the glucagon-like peptide-1 receptor (GLP-1R) deliver significant beneficial effects both in treating type 2 diabetes and obesity ( Reports of the effects of GLP-1R agonists in individuals with inherited lipodystrophies are currently limited to only 3 case studies, and these examine FPLD but not CGL patients ( Here we used a well validated Bscl2 -null (seipin knockout) mouse model of CGL type 2 (CGL2) to examine the effectiveness of a GLP-1R agonist, in treating lipoatrophic diabetes, hepatic steatosis and hyperphagia in CGL to inform the adoption of this class of drugs for individuals with lipodystrophy
These results suggest that targeting screen time especially when its related to excessive social media and video games could be a pathway to preventing or treating manic symptoms for this age group
110 - 116 Copyright Copyright The Authors 2008 Over the last few years, increasing evidence has shown that hyperhomocysteinaemia is an independent risk factor for the development of CVD ( Reference Wyss and Schulze 1 , Reference Harbor-Gonalves, Vaz and Bezzi 2 ) and may be associated with neurodegenerative disease ( Reference Obeid and Herrmann 3 , Reference Bender, Koch and Elstner 4 ) , diabetes ( Reference Wijekoon, Brosnan and Brosnan 5 ) and end-stage renal dysfunction ( Reference Taes, Delanghe and De Vriese 6 , Reference Taes, Delanghe and De Bacquer 7 )
These factors must be continuously monitored and followed to modify the treatment plan effectively
